Showing results (171-180 of 451) with videos related to
Sort By:
Pageof 46
Stem Cell Research & Therapy|February 9, 2017
Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicineMichelle Griffin, Caroline M Ryan, Omar Pathan, et al.Clinical Rheumatology|September 5, 2019
Optimisation of botulinum toxin type a treatment for the management of Raynaud's phenomenon using a dorsal approach: a prospective case seriesKiran Dhaliwal, Michelle F Griffin, Sebastian Salinas, et al.European Journal of Clinical Investigation|October 6, 2018
Functional and phenotypic heterogeneity of Th17 cells in health and diseaseJonas Bystrom, Felix I L Clanchy, Taher E Taher, et al.JAMA Dermatology|May 26, 2021
A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis: A Narrative ReviewMichael Hughes, Yannick Allanore, Khadija El Aoufy, et al.The Journal of Rheumatology|April 15, 2025
Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III AntibodiesElizabeth R Volkmann, Shervin Assassi, Christopher P Denton, et al.Respiratory Medicine|August 6, 2016
Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trialAryeh Fischer, Christopher P Denton, Marco Matucci-Cerinic, et al.Rheumatology (Oxford, England)|July 21, 2022
Macrophages as determinants and regulators of fibrosis in systemic sclerosisYehya Al-Adwi, Johanna Westra, Harry van Goor, et al.Rheumatology (Oxford, England)|August 3, 2010
Clinical experience with bosentan and sitaxentan in connective tissue disease-associated pulmonary arterial hypertensionChristopher J Valerio, Clive E Handler, Peter Kabunga, et al.Arthritis Research & Therapy|March 9, 2017
Multiplex serum protein analysis reveals potential mechanisms and markers of response to hyperimmune caprine serum in systemic sclerosisNiamh Quillinan, Kristina E N Clark, Bryan Youl, et al.Plos One|October 14, 2009
Rac inhibition reverses the phenotype of fibrotic fibroblastsShi-wen Xu, Shangxi Liu, Mark Eastwood, et al.Pageof 46